Skip to main content
logo
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.170
-0.110 (-4.82%)
At close: Mar 13, 2026, 4:00 PM EDT
2.180
+0.010 (0.45%)
After-hours: Mar 13, 2026, 7:48 PM EDT

TherapeuticsMD Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Cap
25102653155363
Market Cap Growth
151.16%-61.78%-51.13%-65.69%-57.33%-44.73%
Enterprise Value
24.4810.428.1522.497.92528.6
Last Close Price
2.170.862.255.5918.0060.50
PE Ratio
83.17-4.30-3.040.47-1.81-1.82
PS Ratio
8.985.6319.930.7660.155.59
PB Ratio
0.920.360.891.51-1.65-2.93
P/TBV Ratio
0.910.360.801.49-1.53-2.69
P/FCF Ratio
12.158.48-1.125.67-2.81-2.27
P/OCF Ratio
12.158.48-1.125.67-2.81-2.27
EV/Sales Ratio
8.765.9121.620.3238.068.15
EV/EBITDA Ratio
--2.45-3.709.39-1.24-3.49
EV/EBIT Ratio
--2.18-3.3018.80-1.23-3.40
EV/FCF Ratio
11.848.89-1.222.39-1.77-3.31
Debt / Equity Ratio
0.200.200.220.21-0.09-1.99
Debt / EBITDA Ratio
-2.29-1.30-0.863.09-2.49-1.63
Debt / FCF Ratio
2.584.74-0.280.79-3.56-1.54
Net Debt / Equity Ratio
-0.060.020.08-0.87-1.40-1.34
Net Debt / EBITDA Ratio
0.72-0.11-0.29-12.88-1.67-1.09
Net Debt / FCF Ratio
-0.810.41-0.10-3.28-2.38-1.04
Asset Turnover
0.070.040.020.540.010.29
Inventory Turnover
----0.351.61
Quick Ratio
2.181.671.080.810.261.91
Current Ratio
2.932.371.721.180.472.17
Return on Equity (ROE)
0.27%-8.16%-23.90%-3.67%72.88%319.73%
Return on Assets (ROA)
-51.75%-11.44%-12.67%0.92%-45.33%-69.50%
Return on Invested Capital (ROIC)
-66.12%-13.98%-25.22%2.00%-122.67%-330.81%
Return on Capital Employed (ROCE)
-8.15%-13.58%-21.29%-5.98%-408.58%-92.76%
Earnings Yield
1.20%-23.26%-32.89%213.95%-55.33%-55.02%
FCF Yield
8.23%11.80%-88.95%17.63%-35.65%-44.02%
Buyback Yield / Dilution
-0.00%-12.14%-4.65%-119.32%-8.82%
Total Shareholder Return
-0.00%-12.14%-4.65%-119.32%-8.82%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q